"Suboxone treatment, a primary MOUD and the current standard of care according to public health officials and the American Society of Addiction Medicine, comes with high costs to quality of life, which its proponents often overlook. The term 'harm reduction' refers to almost any strategy used to save lives by minimizing the negative consequences of addiction, especially homelessness and overdose deaths."
"Kennedy's Safety Through Recovery, Engagement, and Evidence-based Treatment (STREETS) Initiative, launched in early February, emphasizes abstinence-based outpatient treatment, which many public health officials and addiction scientists object to in favor of harm reduction, particularly medications for opioid use disorder (MOUDs)."
"Suboxone contains both buprenorphine, itself a powerful opioid, and naloxone (Narcan), which, at the doses prescribed, partially blocks opioid receptors. Buprenorphine prevents withdrawal on the one hand, while naloxone reduces chances of overdose on the other."
Opioid use disorder medications, particularly Suboxone, have become the standard treatment in the U.S. within a harm reduction framework focused on preventing overdose deaths and homelessness. However, Suboxone's physical and psychological side effects are frequently minimized despite their substantial impact on quality of life. The STREETS Initiative, launched by HHS Secretary Robert F. Kennedy Jr., advocates for abstinence-based outpatient treatment as a preferable option for many individuals suited to it, not as an exclusive approach. While Suboxone contains buprenorphine and naloxone to prevent withdrawal and reduce overdose risk, public health officials have overlooked the significant costs to patients' overall well-being in their emphasis on life-saving interventions.
#opioid-use-disorder-treatment #suboxone-medication-assisted-treatment #abstinence-based-recovery #harm-reduction-debate #quality-of-life-in-addiction-treatment
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]